[go: up one dir, main page]

IL142996A0 - New derivatives of erythromycin, their preparation process and their use as medicaments - Google Patents

New derivatives of erythromycin, their preparation process and their use as medicaments

Info

Publication number
IL142996A0
IL142996A0 IL14299699A IL14299699A IL142996A0 IL 142996 A0 IL142996 A0 IL 142996A0 IL 14299699 A IL14299699 A IL 14299699A IL 14299699 A IL14299699 A IL 14299699A IL 142996 A0 IL142996 A0 IL 142996A0
Authority
IL
Israel
Prior art keywords
erythromycin
medicaments
preparation process
new derivatives
derivatives
Prior art date
Application number
IL14299699A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL142996A0 publication Critical patent/IL142996A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL14299699A 1998-11-10 1999-11-09 New derivatives of erythromycin, their preparation process and their use as medicaments IL142996A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9814145A FR2785612A1 (fr) 1998-11-10 1998-11-10 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1999/002718 WO2000027857A2 (fr) 1998-11-10 1999-11-09 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
IL142996A0 true IL142996A0 (en) 2002-04-21

Family

ID=9532584

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14299699A IL142996A0 (en) 1998-11-10 1999-11-09 New derivatives of erythromycin, their preparation process and their use as medicaments
IL142996A IL142996A (en) 1998-11-10 2001-05-06 Derivatives of erythromycin, method of preparation and their use as drugs

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL142996A IL142996A (en) 1998-11-10 2001-05-06 Derivatives of erythromycin, method of preparation and their use as drugs

Country Status (28)

Country Link
US (2) US6455505B2 (es)
EP (1) EP1016669B1 (es)
JP (1) JP4698783B2 (es)
KR (1) KR100567695B1 (es)
CN (2) CN1240708C (es)
AR (1) AR025814A1 (es)
AT (1) ATE232879T1 (es)
AU (1) AU766138B2 (es)
BR (1) BR9915236A (es)
CA (1) CA2350651C (es)
CZ (1) CZ20011622A3 (es)
DE (1) DE69905447T2 (es)
DK (1) DK1016669T3 (es)
EA (1) EA200100533A1 (es)
ES (1) ES2189365T3 (es)
FR (1) FR2785612A1 (es)
HR (1) HRP20010335B1 (es)
HU (1) HUP0104035A3 (es)
IL (2) IL142996A0 (es)
NO (1) NO20012272L (es)
NZ (1) NZ511609A (es)
PL (1) PL348098A1 (es)
PT (1) PT1016669E (es)
SI (1) SI20640A (es)
TR (1) TR200101286T2 (es)
TW (1) TWI237027B (es)
WO (1) WO2000027857A2 (es)
ZA (1) ZA200103801B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20012675A3 (cs) * 1999-01-27 2002-04-17 Pfizer Products Inc. Ketolidová antibiotika
CA2373117C (en) 1999-05-24 2006-02-28 Pfizer Products Inc. 13-methyl-erythromycin derivatives
EP1167376B1 (en) 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolide antibiotics
JP2004017020A (ja) * 2002-06-20 2004-01-22 Sony Corp コーティング方法および被コーティング粒子
EP3738591A3 (en) 2003-03-10 2021-03-24 Merck Sharp & Dohme Corp. Novel antibacterial agents
WO2006080954A1 (en) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2009055557A1 (en) * 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
HRP20160222T1 (hr) * 2008-10-24 2016-04-08 Cempra Pharmaceuticals, Inc. Biozaštite uporabom makrolida koji sadrže triazol
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
AU2010292010B2 (en) 2009-09-10 2016-01-07 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
NZ602544A (en) 2010-03-22 2014-11-28 Cempra Pharmaceuticals Inc Crystalline forms of a macrolide, and uses therefor
RU2608390C2 (ru) 2010-05-20 2017-01-18 Семпра Фармасьютикалз, Инк. Способы получения макролидов и кетолидов, и промежуточных соединений для их получения
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
HK1205939A1 (en) 2012-03-27 2015-12-31 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
HK1217665A1 (zh) 2013-03-14 2017-01-20 森普拉制药公司 用於治療呼吸道疾病的方法及其製劑
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CA3130061C (en) * 2013-04-04 2024-05-28 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
US10633407B2 (en) 2014-10-08 2020-04-28 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
JP2018509452A (ja) 2015-03-25 2018-04-05 プレジデント アンド フェローズ オブ ハーバード カレッジ 修飾デソサミン糖をもつマクロライドおよびその使用
EP3190122A1 (en) * 2016-01-08 2017-07-12 LEK Pharmaceuticals d.d. A novel synthetic pathway towards solithromycin and purification thereof
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
FR2669337B1 (fr) * 1990-11-21 1995-03-24 Roussel Uclaf Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments.
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CA2263972C (en) * 1996-09-04 2008-01-29 Abbott Laboratories 6-o-substituted ketolides having antibacterial activity
WO1998040392A1 (fr) * 1997-03-10 1998-09-17 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a

Also Published As

Publication number Publication date
ES2189365T3 (es) 2003-07-01
EA200100533A1 (ru) 2001-10-22
AR025814A1 (es) 2002-12-18
DE69905447D1 (de) 2003-03-27
NO20012272L (no) 2001-07-10
HUP0104035A3 (en) 2003-12-29
JP2000143689A (ja) 2000-05-26
NZ511609A (en) 2003-07-25
PL348098A1 (en) 2002-05-06
PT1016669E (pt) 2003-07-31
TR200101286T2 (tr) 2001-09-21
HRP20010335A2 (en) 2002-06-30
US6407257B1 (en) 2002-06-18
US20020013281A1 (en) 2002-01-31
CA2350651C (fr) 2010-07-20
AU766138B2 (en) 2003-10-09
HUP0104035A2 (hu) 2002-02-28
WO2000027857A2 (fr) 2000-05-18
FR2785612A1 (fr) 2000-05-12
KR20010080970A (ko) 2001-08-25
TWI237027B (en) 2005-08-01
AU1052600A (en) 2000-05-29
ATE232879T1 (de) 2003-03-15
US20020028781A1 (en) 2002-03-07
DE69905447T2 (de) 2003-07-24
BR9915236A (pt) 2002-01-08
US6455505B2 (en) 2002-09-24
NO20012272D0 (no) 2001-05-09
ZA200103801B (en) 2002-05-10
CN1333782A (zh) 2002-01-30
DK1016669T3 (da) 2003-05-26
EP1016669A1 (fr) 2000-07-05
CN1240708C (zh) 2006-02-08
IL142996A (en) 2006-12-10
KR100567695B1 (ko) 2006-04-05
CZ20011622A3 (cs) 2001-09-12
CN1814592A (zh) 2006-08-09
JP4698783B2 (ja) 2011-06-08
CA2350651A1 (fr) 2000-05-18
WO2000027857A3 (fr) 2000-08-17
HRP20010335B1 (en) 2003-08-31
EP1016669B1 (fr) 2003-02-19
CN100351238C (zh) 2007-11-28
SI20640A (sl) 2002-02-28

Similar Documents

Publication Publication Date Title
SI0680967T1 (en) Erythromycin derivatives, their process of preparation and their use as medicaments
AP9500743A0 (en) New erythromycin derivatives, their preparation process and their use as medicaments
IL142996A0 (en) New derivatives of erythromycin, their preparation process and their use as medicaments
HUP0000658A3 (en) Sulphonamide derivatives, process for their preparation, and their use as medicaments
PL344412A1 (en) Pyrazoline derivatives, their preparation and application as medicaments
HUP0105136A3 (en) Amide derivatives, process for their preparation and medicaments containing them
PL347506A1 (en) 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
HUP0203548A3 (en) New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use
ZA971659B (en) Erythromycin derivatives, their preparation process and their use as medicaments.
HUP9900958A3 (en) New derivatives of 2-fluoro-3-de[(2,6-dideoxy-3-c-methyl-3-0-methyl-alfa-l-ribohexopyranosyl)-oxy]-6-0-methyl-3-oxo-erytromycin, and their preparation process
ZA997176B (en) Derivatives of erythromycin, their preparation process and their use as medicaments.
LT2000004A (en) Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
PL343512A1 (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
HUP0100978A3 (en) Benzothiadiazoles and derivatives, process for their preparation and medicaments containing them
HUP0100927A3 (en) Antitumor substituted indene-derivatives, process for their preparation, medicaments containing them and their use
HUP0104033A3 (en) 1-benzoyl-tetrahydropyridazine derivatives, process for their preparation, their use and medicaments containing the compounds
HUP0104620A3 (en) 2-phenylpyran-4-one derivatives, process for their preparation and medicaments containing them
HUP0101234A3 (en) Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof
AU3853597A (en) New derivatives of erythromycin, their preparation process and their use as medicaments
AU5487798A (en) New derivatives of erythromycin, their preparation process and their use as medicaments
HUP0001245A3 (en) Novel erythromycin derivatives, method of preparation and application as medicines
HUP0204572A3 (en) Substituierte bisindolylmaleinimide derivatives, process for their preparation and use and pharmaceutcial compositions containing them
SI0863139T1 (en) Benzoxazindione derivatives, process for their preparation and their use
HUP0001452A3 (en) Novel erythromycin derivatives, method of preparation and application as medicines
HUP0102854A3 (en) Cyanoiminoquinoxaline derivatives, process for their preparation, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted
KB Patent renewed